High-Intensity Transcranial Alternating Current Stimulation for Emotion Regulation and Attentional Bias in
-
By
-
Tiejun Kang
-
Xuan Zhao
-
Xiaoning Huo
-
Xuan Liu
-
Yannan Wang
-
Xinlin Wang
-
Xiaobin Ding
-
Heng Wu
-
June 9, 2026
-
Clinical Scorecard: Transcranial Alternating Current Stimulation at High Intensity for Managing Emotions and Attention Bias
At a Glance
| Category | Detail |
|---|
| Condition | Nonsuicidal self-injury (NSSI) in adolescents with major depressive disorder (MDD) - prevalence statistics needed. |
| Key Mechanisms | Deficits in emotion regulation and attentional bias toward self-injury-related cues. |
| Target Population | Adolescents aged 12 to 18 years with MDD and NSSI. |
| Care Setting | Psychiatric inpatient and outpatient departments. |
Key Highlights
- NSSI is a prevalent behavior among adolescents, particularly females - include statistics.
- Emotion regulation deficits are central to NSSI development and maintenance.
- High-intensity transcranial alternating current stimulation (HI-tACS) targets prefrontal-limbic circuits.
- Gamma-frequency HI-tACS may enhance cognitive functions related to emotion regulation - clarify significance.
- The study employs a double-blind, sham-controlled randomized clinical trial design.
Guideline-Based Recommendations
Diagnosis
- Current major depressive episode confirmed by DSM-5.
- At least 3 NSSI episodes in the month before enrollment.
Management
- HI-tACS targeting the prefrontal cortex to improve emotion regulation and attentional bias.
Monitoring & Follow-up
- Assess for suicidal intent and monitor adherence to treatment - specify assessment tools.
Risks
- Exclusion of participants with current substance use disorder, bipolar disorder, or significant neurological disorders.
Patient & Prescribing Data
Adolescents aged 12 to 18 years with MDD and NSSI.
HI-tACS sessions are conducted twice daily for 3 weeks - include side effects or contraindications.
Clinical Best Practices
- Conduct thorough assessments for suicidal intent before enrollment.
- Ensure informed consent from participants and legal guardians.
- Maintain blinding integrity throughout the trial.
- Add recommendations for follow-up care post-treatment.
Related Resources & Content
